Literature DB >> 18223696

Successful treatment of a patient with Klinefelter's syndrome complicated by mediastinal germ cell tumor and AML(M7).

H Hiramatsu, T Morishima, H Nakanishi, Y Mizushima, M Miyazaki, H Matsubara, M Kobayashi, T Nakahata, S Adachi.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18223696     DOI： 10.1038/sj.bmt.1705991

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  10 in total

1.  Malignant transformations in a patient with a mediastinal germ cell tumour: lack of efficacy of bone marrow transplantation after chemotherapy on tumour recurrence.

Authors:  Yusra Kassim; Dominique Penther; Pascale Schneider; Marie-Paul Callat; Christian Bastard; Jean-Pierre Vannier
Journal:  BMJ Case Rep       Date:  2012-06-14

2.  Survival Outcomes of Patients With Primary Mediastinal Germ Cell Tumors: A Retrospective Single-institutional Experience.

Authors:  Hiroshi Yaegashi; Takahiro Nohara; Kazuyoshi Shigehara; Kouji Izumi; Yoshifumi Kadono; Tomoyuki Makino; Kaname Yamashita; Koushiro Ohtsubo; Hiroko Ikeda; Atsushi Mizokami
Journal:  Cancer Diagn Progn       Date:  2022-05-03

3.  Klinefelter syndrome in males with germ cell tumors: A report from the Children's Oncology Group.

Authors:  Lindsay A Williams; Nathan Pankratz; John Lane; Mark Krailo; Michelle Roesler; Michaela Richardson; A Lindsay Frazier; James F Amatruda; Jenny N Poynter
Journal:  Cancer       Date:  2018-10-06       Impact factor: 6.860

4.  Acute myeloid leukemia in a patient with constitutional 47,XXY karyotype.

Authors:  Marla M Jalbut; Aliyah R Sohani; Paola Dal Cin; Robert P Hasserjian; Jenna A Moran; Andrew M Brunner; Amir T Fathi
Journal:  Leuk Res Rep       Date:  2015-04-22

5.  Malignant phyllodes tumor and acute megakaryoblastic leukemia sharing a common clonal origin.

Authors:  Yngvar Fløisand; Klaus Beiske; Geir Erland Tjønnfjord; Dag Heldal; Bodil Bjerkehagen; Mona-Elisabeth Revheim; Sverre Heim; Oyvind Sverre Bruland; Kirsten Sundby Hall; Anne Tierens; Jan Delabie
Journal:  Case Rep Hematol       Date:  2013-12-17

6.  A common founding clone with TP53 and PTEN mutations gives rise to a concurrent germ cell tumor and acute megakaryoblastic leukemia.

Authors:  Charles Lu; Peter Riedell; Christopher A Miller; Ian S Hagemann; Peter Westervelt; Bradley A Ozenberger; Michelle O'Laughlin; Vincent Magrini; Ryan T Demeter; Eric J Duncavage; Malachi Griffith; Obi L Griffith; Lukas D Wartman
Journal:  Cold Spring Harb Mol Case Stud       Date:  2016-01

7.  Functional and genetic screening of acute myeloid leukemia associated with mediastinal germ cell tumor identifies MEK inhibitor as an active clinical agent.

Authors:  Jessica T Leonard; Philipp W Raess; Jennifer Dunlap; Brandon Hayes-Lattin; Jeffrey W Tyner; Elie Traer
Journal:  J Hematol Oncol       Date:  2016-03-31       Impact factor: 17.388

8.  TP53 and PTEN mutations were shared in concurrent germ cell tumor and acute megakaryoblastic leukemia.

Authors:  Keiichi Akizuki; Masaaki Sekine; Yasunori Kogure; Takuro Kameda; Kotaro Shide; Junji Koya; Ayako Kamiunten; Yoko Kubuki; Yuki Tahira; Tomonori Hidaka; Takumi Kiwaki; Hiroyuki Tanaka; Yuichiro Sato; Hiroaki Kataoka; Keisuke Kataoka; Kazuya Shimoda
Journal:  BMC Cancer       Date:  2020-01-02       Impact factor: 4.430

9.  Salvage Cord Blood Transplantation for Sustained Remission of Acute Megakaryoblastic Leukemia That Relapsed Early after Myeloablative Transplantation.

Authors:  Satoshi Ichikawa; Tohru Fujiwara; Kei Saito; Kazuki Sakurai; Kyoko Inokura; Noriko Fukuhara; Hisayuki Yokoyama; Koichi Onodera; Yasushi Onishi; Junichi Kameoka; Hideo Harigae
Journal:  Intern Med       Date:  2021-04-05       Impact factor: 1.271

10.  Mediastinal Germ Cell Tumor-associated Histiocytic Proliferations Treated With Thalidomide Plus Chemotherapy Followed by Alemtuzumab-containing Reduced Intensity Allogeneic Peripheral Blood Stem Cell Transplantation: A Case Report.

Authors:  Li-Hua Fang; Li-Sun Shih; Pei-Ing Lee; Wei-Ting Chen; Rong-Long Chen
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.